Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Multisite Crossover Trial Evaluating the Efficacy of NeoThelium FT in the Treatment of "Other" Open Wounds

NCT06918561 is registered in ClinicalTrials.gov with NuScience Medical Biologics, LLC as lead sponsor.

NCT NCT06918561
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06918561 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Multisite Crossover Trial Evaluating the Efficacy of NeoThelium FT in the Treatment of "Other" Open Wounds
Lead sponsor
NuScience Medical Biologics, LLC
Phase
Not applicable
Overall status
Recruiting
Start date
October 16, 2025
Completion date
October 1, 2026
Enrollment
132 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

open wound